Strong 1Q for Covidien, but Bolstered by Several Nonrecurring BenefitsBy Martin FloresJanuary 26, 2013 Covidien’s fiscal first-quarter results slightly exceeded our forecast, but we’re cognizant of several unexpected benefits that helped top-line growth in…